Drugs seized from US manufacturer for cGMP violations
This article was originally published in SRA
Executive Summary
Federal law enforcement officers, at the request of the US Food and Drug Administration, have seized some 33 drug products in multiple strengths, as well as raw ingredients, from Caraco Pharmaceutical Laboratories’ plants in Detroit, Farmington Hills and Wixom, Michigan1. The FDA says the firm has not taken appropriate steps to correct violations of current good manufacturing practices at these locations.